1. West Nile Virus Seroprevalence in an Outdoor Nonhuman Primate Breeding Colony in South Florida
- Author
-
Angus Cameron, Wesley M Burnside, Pablo R Morales, and Stara N Robertson
- Subjects
Male ,Health Surveillance ,West Nile virus ,viruses ,animal diseases ,Viremia ,Breeding ,Antibodies, Viral ,medicine.disease_cause ,Hamadryas ,Seroepidemiologic Studies ,medicine ,Animals ,Humans ,Seroprevalence ,Hamadryas baboon ,Papio hamadryas ,biology ,Monkey Diseases ,virus diseases ,biology.organism_classification ,medicine.disease ,Macaca mulatta ,Virology ,Macaca fascicularis ,Infectious disease (medical specialty) ,Florida ,biology.protein ,Animal Science and Zoology ,Antibody ,West Nile Fever - Abstract
West Nile virus (WNV) was first detected in Florida in July 2001, with 404 human cases reported to the Centers for Disease Control and Prevention as of February 2020. The subtropical climate of Florida is ideal for the mosquitoes that transmit WNV. We investigated the WNV seroprevalence in 3 NHP species housed outdoors at The Mannheimer Foundation in South Florida. From January to December 2016, 520 3 to 30 y old NHP were sampled at our 2 closed sites in Homestead and LaBelle: 200 rhesus macaques (Macaca mulatta), 212 cynomolgus macaques (Macaca fascicularis), and 108 hamadryas baboons (Papio hamadryas hamadryas). The presence of WNV IgG antibodies in these animals was determined by serum neutralization assays, which found a total seroprevalence of 14%. Seroprevalence was significantly higher in the baboons (29%) than the rhesus (11%) and cynomolgus (9%) macaques. The probability of seropositivity significantly increased with age, but sex and site did not significantly affect seroprevalence. The frequency of WNV seropositivity detected in these outdoor-housed NHP suggests that screening for WNV and other vector-borne diseases may be necessary prior to experimental use, particularly for infectious disease studies in which viremia or viral antibodies could confound results, and especially for populations housed outdoors in warm, wet climates. As no seropositive subjects demonstrated clinical signs of WNV and WNV exposure did not appear to significantly impact colony health, routine testing is likely unnecessary for most NHP colonies. However, WNV infection should still be considered as a differential diagnosis for any NHP presenting with nonspecific neurologic signs. Mosquito abatement plans and vigilant sanitation practices to further decrease mosquito and avian interaction with research NHP should also be considered.
- Published
- 2021
- Full Text
- View/download PDF